Novartis Builds Antiviral Franchise with Idenix Pharmaceuticals
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 35 (Table of Contents)
Published: 3 Apr-2003
DOI: 10.3833/pdr.v2003.i35.920 ISSN: 1756-7874
Section: Mergers & Acquisitions
Abstract
Novartis entered into an agreement to acquire Idenix Pharmaceuticals by acquiring 51% stake in Idenix, thereby substantially expanding its product portfolio in the field of antiviral drugs...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
Last Issue PDF
RSS